Injectable Platelet Rich Fibrin With Collagen Matrix in Treatment of Multiple Gingival Recession.
Launched by UNIVERSITY OF BAGHDAD · May 20, 2022
Trial Information
Current as of May 29, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Presence of at least two localized gingival recessions on either sides of the maxilla and/or mandible excluding molar region.
- • The cemento-enamel junction (CEJ) is visible in the teeth for root coverage procedures.
- • All recessions are type 1recession RT1 (cairo et al,2011) which correspond to Miller I\&II gingival recession
- • All patients must demonstrate adequate plaque control with a fullmouth plaque score less than 20% and with .
- • All patients at least 18 years of age and of both genders.
- Exclusion Criteria:
- • Smoker Patients .
- • Patients with diabetes.
- • Patients with a history of malignancy, radiotherapy, or chemotherapy for malignancy.
- • pregnant or nursing women.
- • Patients taking medications or having treatments with an effect on mucosal healing in general (e.g. steroids, large doses of antiinflammatory drugs).
- • Patients with a disease affecting connective tissue metabolism.
- • Patients allergic to collagen.
About University Of Baghdad
The University of Baghdad, a leading academic institution in Iraq, is committed to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary approaches, the university leverages its extensive network of experts and state-of-the-art facilities to conduct rigorous clinical studies. The institution aims to contribute valuable insights into various health conditions, fostering an environment of scientific inquiry and ethical research practices that ultimately enhance patient care and public health in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baghdad, , Iraq
Patients applied
Trial Officials
Basima Gh Ali, MSc
Principal Investigator
University of Baghdad
Thair AL Hassan, PHD
Study Director
University of Baghdad
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials